These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38751758)

  • 1. Age-related factors associated with intention to initiate pre-exposure prophylaxis among cisgender women in Washington D.C.
    Zack JL; Hull SJ; Coleman ME; Ye PP; Lotke PS; Visconti A; Beverley J; Brant A; Moriarty P; Scott RK
    Ther Adv Infect Dis; 2024; 11():20499361241252351. PubMed ID: 38751758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated with Intention to Initiate Pre-exposure Prophylaxis in Cisgender Women at High Behavioral Risk for HIV in Washington, D.C.
    Scott RK; Hull SJ; Huang JC; Coleman M; Ye P; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Cameron M; Elion R; Visconti A
    Arch Sex Behav; 2022 Jul; 51(5):2613-2624. PubMed ID: 35622077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intention to Initiate HIV Pre-exposure Prophylaxis Among Cisgender Women in a High HIV Prevalence U.S. City.
    Scott RK; Hull SJ; Huang JC; Ye PP; Lotke P; Beverley J; Moriarty P; Balaji D; Ward A; Holiday J; Brant AR; Elion R; Visconti AJ; Coleman M
    Womens Health Issues; 2023; 33(5):541-550. PubMed ID: 37479630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Moderating Effects of HIV Relevant Factors on the Relationship Between Intimate Partner Violence and Intention to Start HIV Pre-exposure Prophylaxis (PrEP) Among Cisgender Women.
    Keddem S; Frye V; Davis A; Koblin BA; Tieu HV; Lipsky RK; Nandi V; Teitelman AM
    Arch Sex Behav; 2024 Apr; 53(4):1531-1539. PubMed ID: 38366311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, acceptability, and intention to initiate HIV pre-exposure prophylaxis among pregnant women.
    Scott RK; Hull SJ; Richards RC; Klemmer K; Salmoran F; Huang JC
    AIDS Care; 2022 Feb; 34(2):201-213. PubMed ID: 33874801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs.
    Darlington CK; Lipsky RK; Teitelman AM; Koblin BA; Davis A; Walcott M; Compton PA; Tieu HV
    J Subst Use Addict Treat; 2023 Sep; 152():209119. PubMed ID: 37451517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying an Evidence-Based Community Organizing Approach to Strengthen HIV Prevention for Cisgender Women in US South: Protocol for a Mixed Methods Study.
    Sheth AN; Dixon Diallo D; Ellison C; Er DL; Ntukogu A; Komro KA; Sales JM
    JMIR Res Protoc; 2024 Mar; 13():e56293. PubMed ID: 38517456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Psychosocial Determinants of PrEP Uptake Among Cisgender Women Experiencing Heightened HIV Risk: Implications for Multi-Level Communication Intervention.
    Hull SJ; Duan X; Brant AR; Peng Ye P; Lotke PS; Huang JC; Coleman ME; Nalls P; Scott RK
    Health Commun; 2023 Dec; 38(14):3264-3275. PubMed ID: 36398676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrEP acceptability and initiation among women engaged in sex work in Uganda: Implications for HIV prevention.
    Witte SS; Filippone P; Ssewamala FM; Nabunya P; Bahar OS; Mayo-Wilson LJ; Namuwonge F; Damulira C; Tozan Y; Kiyingi J; Nabayinda J; Mwebembezi A; Kagaayi J; McKay M
    EClinicalMedicine; 2022 Feb; 44():101278. PubMed ID: 35128367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keeping it real: A descriptive analysis of HIV testing history, PrEP awareness, and PrEP use among Black cisgender women in Middle Tennessee, 2018.
    Alexander LR; Brown VL; Koethe JR; Shepherd BE; Green M; Myers HF; Chandler CJ
    J Natl Med Assoc; 2024 Aug; 116(4):338-350. PubMed ID: 39048497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence in Ability to Communicate With Sexual Partners About PrEP Among Black Cisgender Women.
    Irie W; Mahone A; Nakka R; Ghebremichael M
    AIDS Educ Prev; 2023 Oct; 35(5):333-346. PubMed ID: 37843905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Influences on Intention to Use Pre-exposure Prophylaxis (PrEP) Among African American Young Adults.
    Ayangeakaa SD; Kerr J; Combs R; Harris L; Sears J; Parker K; Sterrett-Hong E
    J Racial Ethn Health Disparities; 2023 Apr; 10(2):899-910. PubMed ID: 35290648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where's the "Everyday Black Woman"? An intersectional qualitative analysis of Black Women's decision-making regarding HIV pre-exposure prophylaxis (PrEP) in Mississippi.
    Willie TC; Knight D; Baral SD; Chan PA; Kershaw T; Mayer KH; Stockman JK; Adimora AA; Monger M; Mena LA; Philllips KA; Nunn A
    BMC Public Health; 2022 Aug; 22(1):1604. PubMed ID: 35999528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes Toward and Experiences With Discussing Pre-exposure Prophylaxis With Sexual Partners Among US Adolescents and Young Adults Living With HIV.
    Lehmann C; Mullins TLK
    J Adolesc Health; 2023 Nov; 73(5):866-872. PubMed ID: 37318410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of male partners in women's participation in research during pregnancy: a case study from the partners demonstration project.
    Ngure K; Trinidad SB; Beima-Sofie K; Baeten JM; Mugo NR; Bukusi EA; Heffron R; John-Stewart G; Kelley MC
    Reprod Health; 2017 Dec; 14(Suppl 3):160. PubMed ID: 29297375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project.
    Blumenthal J; Landovitz R; Jain S; He F; Kofron R; Ellorin E; Ntim GM; Stockman JK; Corado K; Rivet Amico K; Moore DJ; Morris S
    AIDS Patient Care STDS; 2021 Dec; 35(12):481-487. PubMed ID: 34851726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Pre-exposure Prophylaxis Awareness and Use Among Cisgender Women at a Sexually Transmitted Disease Clinic.
    Raifman JR; Schwartz SR; Sosnowy CD; Montgomery MC; Almonte A; Bazzi AR; Drainoni ML; Stein MD; Willie TC; Nunn AS; Chan PA
    J Acquir Immune Defic Syndr; 2019 Jan; 80(1):36-39. PubMed ID: 30531295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States.
    Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH
    J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A secondary gendered analysis of interviews with Latina cisgender women indicated for HIV pre-exposure prophylaxis.
    Lim S; Mantsios A; Braithwaite RS; Pitts R
    AIDS Care; 2024 May; 36(5):692-702. PubMed ID: 38466205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.